Kyle Ockerman

Mr. Kyle Ockerman


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2024 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
KOKyle Ockerman
Kyle Ockerman
MMMarkos Mardourian
Markos Mardourian
SHSabrina Haejung Han
Sabrina Haejung Han
MPMichael Petrauskis
Michael Petrauskis
SSSarah Sorice-Virk
Sarah Sorice-Virk
JCJessica Ching
Jessica Ching

20 September 2024 in Surgical Techniques Development
Verified
Journal Article
Open access
PDF file
KOKyle Ockerman
Kyle Ockerman
NTNhan Sinh Trieu
Nhan Sinh Trieu
SHSabrina Haejung Han
Sabrina Haejung Han
MMMarkos Mardourian
Markos Mardourian
LSLisa R Spiguel
Lisa R Spiguel
SSSarah Sorice-Virk
Sarah Sorice-Virk
Introduction: Mastectomy skin necrosis (MSN) is a common complication occurring in up to 50% of patients. In patients with risk factors for poor wound healing such as immunosuppression, prior radiotherapy (XRT), and high body mass index (BMI > 30.0), this number is even higher. MSN can lead to infection, loss of reconstruction, poorer aesthetics, and most ominously, delay in adjuvant cancer therapy. Instead of forgoing reconstruction in these patients, adjunctive therapies to optimize wound healing are necessary. The purpose of this study is to introduce the use of cryopreserved umbilical tissue (vCUT) as an adjunct therapy for high-risk-wound-healing immediate breast reconstruction (IBR) patients. Methods: All patients who underwent breast reconstruction with vCUT as an adjunctive therapy were identified and retrospectively analyzed. Results: Seven patients who underwent breast reconstruction with vCUT placement were identified. These patients had risk factors for delayed healing, such as obesity, immunosuppression, and/or prior XRT. The mean post-operative follow-up was 252 days (range 183–287). Four out of seven patients demonstrated post-operative complications: two out of seven developed seromas, two out of seven developed wound dehiscence, two out of seven developed infection, two out of seven developed MSN, and two out of seven lost their reconstruction. Conclusion: As undergoing IBR leads to improved mental health and superior aesthetic outcomes, efforts to expand current indications for safe IBR to traditionally poorer reconstructive candidates are imperative. The results of this case series demonstrate vCUT as a promising novel adjunctive tool in the reconstructive surgeons’ armamentarium in managing the less ideal reconstructive breast candidate.